Antibiotics Flashcards

1
Q

Beta-lactams

A

Penicillins (natural, antistaphylococcal, extended-spec, and antipseudomonal)
Cephalosporins (1-5)
Carbapenems
Monobactams

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Cell-wall synthesis inhibitors

A

beta-lactams (PBPs = no synthesis of stable cell wall), vanco (transglycosylase = prevent binding of peptidoglycans, bacitracin (interferes with transport across cell)
Bactericidal, time-dependent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Cell membrane disruption

A

polymyxin, daptomycin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Classes that inhibit protein synthesis

A

Tetracyclines (30S), macrolides (50S), and aminoglycosides (30S - bactericidal)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Classes that inhibit nucleic acid synthesis

A

RNA polymerase inhibitor - rifampin

DNA replication inhibitor - Fluoroquniolones (cirpfloxacin)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Classes that inhibit folic acid synthesis

A

Trimethoprim and sulfonamides (sulfamethoxazole)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Streptococcus treatments

A

Penicillin V
Amoxicillin
Cephalexin
Amoxicillin+clavulanic acid

Allergy to beta-lactam: azithromycin, clarithromycin, clindamycin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

MSSA treatments

A
Nafcillin
Oxacillin
Dicloxacillin
Cephalexin
Amoxicillin+clauvulanic acid
3rd gen cephalosporins for severe infections

Allergy to beta-lactams: azithromycin, clarithromycin, clindamycin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

MRSA treatments

A
Ceftaroline (moderate)
Vanco (severe)
Dapto (severe)
SMX/TMP (mild-moderate)
Doxy (moderate)
Minocycline (moderate)
Clindamycin (moderate)
Linezolid (severe)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Extended spectrum penicillins treat these gram-

A
Haemophilus influenzae
Heliobacter pylori
Escherichia coli
Listeria monocytogenes
Proteus mirabilis
Salmonells
Shigells
Enterococci
(HHELPSSE)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Superinfection

A
  • Broad-spectrum antibiotics (frequent: extended-spec penicillins, cephalosporins, clindamycin, fluoroquinolones; occasionally: TMP/SMX, macrolides)
  • organisms: Clostridium difficile (pseudomembranous colitis), Staphylococcus aureus (entercolitis), candida albicans (vagina and mouth infections)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Activity of cephalosporins moving from 1st to 4th gen

A

Increasing activity against g-, beta-lactamase, pseudomonas, anaerboes; increasing ability to cross BBB

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

1st gen cephalosporins

A
  • Cephalexin, cefazolin
  • g+ (staph and strep, PEcK - proteus mirabilis, E.coli, and Klebsiella pneumoniae
  • UTI
  • SSTI caused by staph and strep like cellulitis or abscess
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Vancomycin use

A

MRSA, Enterocolitis, C. diff, enterococci

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Vanco adverse effects

A

Nephrotoxicity
Ototoxicity
Thrombophlebitis
Red man syndrome - histamine release (pre-treat with anti-histamine and slow infusion rate)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Vanco resistance

A

D-ala-D-ala to D-ala-D-lactate

17
Q

Dapto clinical use

A

Staph aureus (including MRSA), enterococcus faecalis and faecium, strep pyogenes (GAS)

18
Q

Dapto major side effects

A

Myopathy (elevated CK)

19
Q

Spectrum of polymyxins

A

g- (mostly aerobes - pseudomonas)

20
Q

Clinical use of polymyxins

A

Significant toxicity with systemic use so topical; systemic use limited to serious infections

21
Q

Side effects of polymyxin

A

Nephrotoxicity and neurotoxicity

22
Q

SMX and TMP MOA

A

p-Aminobenzoic acid converted to dihydropteroic acid via dihydropteroate synthase (inhibited by sulfonamides); dihydropteroic acid converted to dihydrofolate via dihydrofolate reductase (inhibited by trimethoprim)

23
Q

SMX/TMP clinical use

A
  • MSSA and mild-moderate MRSA
  • UTI
  • respiratory tract infections (H. influenzeae, strep pneumoniae - increased resistance)
  • enterocolitis (shigella)
  • traveler’s diarrhea (E. coli and shigella)
  • otitis media
24
Q

SMX side effects

A

Allergies (fever, nausea, vomiting, diarrhea, rash, dermatitis, Steven Johnson syndrome); hematological disorders (megaloblastic anemia, leukopenia, granulocytopenia, thrombocytopenia, hemolytic anemia in pt with G6PD deficiency)

25
Side effect unique to SMX
kernicterus in newborns (drug displaces bilirubin from albumin>>free bilirubin deposist in basal ganglia and subthalamic nuclei>>encephalopathy
26
Tetracyclines MOA
Bind to 30S of bacterial ribosome, blocking access of aminoacyl-tRNA to mRNA-ribosome complex
27
Clinical use of tetracyclines
MRSA, anthrax, mycoplasma pneumonia, chlamydia, rickettsiae, Lyme, GI
28
Tetracyclines side effects
GI distress, photosensitivity, discoloration of teeth in children, inhibition of bone growth in children (tetracycline binds to Ca)
29
Macrolides MOA
Binds to 50S to inhibit peptide transfer
30
Macrolides clinical use
Substitute for penicillins, strep and staph (not MRSA), more on g-
31
Major side effects of macrolides
``` MACRO gi Motility Arrythmia acute Cholestatis hepatitis Rash eosinOphilia ```
32
Clindamycin MOA
50S subunit
33
Clindamycin clinical use
strep and staph; anaerobic infections
34
Side effects of clindamycin
Fever, diarrhea, superinfection: pseudomembranous colitis
35
Linezolid MOA
50S
36
Clinical use of linezolid
broad g+ MRSA VRE
37
Side effects of linezolid
bone marrow suppression (thrombocytopenia, anemia, neutropenia), optic and peripheral neuropathy, serotonin syndrome when administered with SSRIs